Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreatic A cell | 4 studies | 58% ± 24% | |
type B pancreatic cell | 4 studies | 68% ± 18% | |
pancreatic D cell | 3 studies | 44% ± 21% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreas | 3 studies | 56% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1818.25 | 328 / 328 | 74% | 45.81 | 131 / 178 |
stomach | 81% | 96.62 | 290 / 359 | 3% | 0.15 | 8 / 286 |
kidney | 74% | 86.51 | 66 / 89 | 7% | 0.28 | 64 / 901 |
intestine | 74% | 42.38 | 716 / 966 | 3% | 2.45 | 18 / 527 |
bladder | 71% | 69.81 | 15 / 21 | 4% | 0.11 | 18 / 504 |
uterus | 69% | 61.64 | 117 / 170 | 2% | 0.06 | 10 / 459 |
breast | 27% | 26.29 | 125 / 459 | 39% | 38.84 | 431 / 1118 |
thymus | 54% | 26.22 | 352 / 653 | 10% | 0.41 | 63 / 605 |
esophagus | 56% | 34.32 | 810 / 1445 | 4% | 0.35 | 7 / 183 |
skin | 23% | 14.24 | 415 / 1809 | 13% | 1.02 | 61 / 472 |
lung | 28% | 15.54 | 164 / 578 | 7% | 0.44 | 81 / 1155 |
prostate | 30% | 20.60 | 73 / 245 | 1% | 0.06 | 7 / 502 |
brain | 29% | 11.06 | 760 / 2642 | 0% | 0.00 | 2 / 705 |
adrenal gland | 21% | 9.85 | 53 / 258 | 0% | 0 | 0 / 230 |
spleen | 17% | 3.98 | 42 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 14% | 6.59 | 185 / 1335 | 0% | 0 | 0 / 0 |
ovary | 12% | 2.53 | 21 / 180 | 1% | 0.02 | 4 / 430 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.21 | 2 / 29 |
peripheral blood | 4% | 1.97 | 33 / 929 | 0% | 0 | 0 / 0 |
heart | 3% | 0.68 | 29 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0.06 | 1 / 226 | 2% | 0.20 | 9 / 406 |
adipose | 2% | 1.10 | 30 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.06 | 4 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071577 | Biological process | zinc ion transmembrane transport |
GO_0009749 | Biological process | response to glucose |
GO_0062111 | Biological process | zinc ion import into organelle |
GO_0060627 | Biological process | regulation of vesicle-mediated transport |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0034341 | Biological process | response to type II interferon |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0006882 | Biological process | intracellular zinc ion homeostasis |
GO_0010043 | Biological process | response to zinc ion |
GO_0006829 | Biological process | zinc ion transport |
GO_0030073 | Biological process | insulin secretion |
GO_0071578 | Biological process | zinc ion import across plasma membrane |
GO_0030070 | Biological process | insulin processing |
GO_0042593 | Biological process | glucose homeostasis |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030141 | Cellular component | secretory granule |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005385 | Molecular function | zinc ion transmembrane transporter activity |
GO_0140826 | Molecular function | zinc:proton antiporter activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC30A8 |
Protein name | Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8) Solute carrier family 30 member 8 Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) |
Synonyms | ZNT8 |
Description | FUNCTION: Proton-coupled zinc ion antiporter mediating the entry of zinc into the lumen of pancreatic beta cell secretory granules, thereby regulating insulin secretion. . FUNCTION: Proton-coupled zinc ion antiporter mediating the entry of zinc into the lumen of pancreatic beta cell secretory granules, thereby regulating insulin secretion. . |
Accessions | ENST00000519688.5 [Q8IWU4-2] A0A096LPF3 ENST00000521243.5 [Q8IWU4-2] ENST00000456015.7 [Q8IWU4-1] ENST00000427715.2 [Q8IWU4-2] ENST00000518521.5 ENST00000524274.5 Q8IWU4 ENST00000518396.5 E5RG87 A0A096LNR0 |